Welltower WELL
Real Estate · REIT - Healthcare Facilities · Synthos Deep Dive · 2026-08-04
The Overview
Welltower owns buildings where old people live and receive care — retirement communities, assisted living, some medical offices — in America, Britain and Canada. Increasingly it does not just own them and collect rent; it runs them, which means it keeps the profit when occupancy and prices rise, and wears the cost when staffing gets expensive. Nearly 80% of its revenue now comes from buildings it operates rather than leases out.
The business is growing very fast. Revenue rose 36% last year and 41% in the three months to June. That is the fastest of any of the twelve companies in this group. Most of it comes from buying more buildings — and in July the company said it had bought or was about to buy more than $5 billion more in the second half of this year.
The reason to be interested is demographic and simple: the number of people over eighty is rising sharply in all three of its markets, and almost nobody has been building this kind of housing because it costs about $450,000 per apartment and financing has been hard to get. Fixed supply, rising demand.
The reason to be careful is how it is paid for. Welltower issues new shares to buy buildings. The number of shares has risen from 605 million to 732 million in two years — 21% more owners sharing the same pie. Sales grew much faster than that, so it has probably been worthwhile, but there is a measurement problem, and it is serious.
Property companies are not valued on ordinary profits, because accounting depreciation on buildings is enormous and largely fictional — buildings do not usually fall in value. The industry uses a measure called funds from operations instead. Our data source provides no such figure for Welltower. The company's own quarterly filing does contain it, but the table it sits in was not captured when the document was processed, so we do not have it.
So we can say the shares look expensive on everything we can measure — about 53 times operating cash flow per share, 13 times sales, and a dividend yield of only 1.3% when this kind of company usually yields 4-6% — but we cannot say what they cost relative to the number the market actually uses. We are telling you that rather than inventing an answer.
The shares are $231.57, up 39% over the past year — the best of these twelve. Our estimate is $232, essentially the current price.
- Downside Risk 6/10. Real buildings, no accounting goodwill, conservative debt — against constant share issuance and a price we cannot measure properly.
- Growth Quality 8/10. The fastest growth here. Bought, not organic, and diluted.
- Exponential Potential 5/10. A genuine multi-decade demographic wave, captured through a vehicle that must keep issuing shares to ride it.
Putting a number on it: our fair-value estimate is $232 against a current price of $237.98 — consistent with our call to stay away or wait for a better setup.
Our summary metrics
"Rated 6 — real assets and a 221-quarter dividend record against relentless equity issuance and a valuation we cannot measure properly. The supports: beta 0.763; total assets of $67.303 billion in physical real estate with ZERO goodwill and ZERO intangibles on the balance sheet, which is unusual and creditable; net debt of $16.347 billion against $43.203 billion of total equity, a 0.425x debt-to-equity ratio that is genuinely conservative for a REIT; $5.034 billion of cash; the 221st consecutive quarterly dividend payable 2026-08-20; and an impairment charge of only $27.181 million on 12 properties in the first half of 2026, down from $33.8 million. Against that: the diluted share count has risen from 604.6 million to 732.1 million in two years — 21.1% dilution — and that is the funding mechanism, not an accident; the company disclosed in July 2026 that it had closed or expected to close MORE THAN $5 billion of further seniors-housing acquisitions in the second half; the Seniors Housing Operating segment at 79.6% of revenue is an OPERATING business with staffing and occupancy risk, not a triple-net lease; and the balance sheet in the payload is seven months old at a moment when the company is transacting at $5 billion a half. The vendor's `interestCoverageRatioTTM` of 0.92x is a depreciation artefact and is rejected, but the underlying point — that GAAP earnings barely cover interest — is a real feature of a REIT at this stage of a build-out."
"Rated 8 — the fastest revenue growth in this batch by a wide margin, and it is bought rather than organic. Revenue went from $4.587 billion in 2020 to $10.667 billion in 2025, and the step change is recent: $7.854 billion in 2024 to $10.667 billion in 2025, +35.8%. The June 2026 quarter did $3.545 billion against $2.516 billion, +40.9%, and beat the $3.403 billion consensus by 4.2%. Seniors Housing Operating — 79.6% of 2025 revenue — grew from $6.035 billion to $8.489 billion, +40.7%. Consensus wants $14.053 billion in 2026 (+31.7%), $15.916 billion in 2027 (+13.3%) and $18.109 billion in 2028 (+13.8%). The 10-Q adds that in July 2026 Welltower 'announced that we have closed or expect to close more than $5 billion of seniors housing acquisitions in the second half of the year'. The demographic driver is genuine and the operator consolidation opportunity is real. What holds this at 8 rather than 10 is that a 21.1% increase in the share count over two years funded it, so per-share growth is materially slower than the headline, and that the payload provides no funds-from-operations series with which to measure per-share growth properly."
"Rated 5 — a genuine demographic slope expressed through a capital-intensive, share-issuing vehicle. The eighty-plus population in the United States, the United Kingdom and Canada — Welltower's three disclosed markets at $7.937 billion, $2.167 billion and $734 million of 2025 revenue — inflects sharply this decade, and seniors-housing supply has been structurally constrained since construction financing tightened. That is a multi-decade demand curve meeting a fixed asset base, which is the best possible setup for an owner. Welltower is also consolidating operators rather than merely landlording: the Seniors Housing OPERATING segment is 79.6% of revenue, meaning the company captures the operating margin rather than a fixed rent, which is where the upside lives if occupancy and rate both rise. Against that, capturing a demographic slope through a REIT requires continuous equity issuance — 21.1% in two years — so the per-share compounding is a fraction of the asset-level compounding, and the vehicle cannot escape that. There is also no knowledge-base corroboration of any kind: zero claims across 51,928 on this name, this sector or this thesis. A 5: a real slope, an inefficient wrapper, and no external validation available to us."
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
The Road Ahead
What we expect to matter in each window, and the evidence that would prove us wrong.
Short term 0-6 months
Neutral- Driver
- "A strong uptrend at a high price with no measurable earnings anchor. Price $231.57 is 8.1% below the 52-week high of $252.07 and 43.1% above the low of $161.88 — the 77th percentile of its annual range. It sits 3.1% above a 50-day average of $224.58 and 13.1% above a 200-day of $204.77, both rising, with RSI at 47.9 and MACD positive at +2.80. The twelve-month return of +39.3% against SPY's +24.3% is the best in this batch, and the six-month return of +23.6% against +11.1% is the second-best. The 2026-07-27 print beat on revenue by 4.2%. On 2026-08-04 the stock fell 0.66% in a market that rose. The problem is not the trend, it is that we cannot price it: the vendor supplies no funds-from-operations figure, the 10-Q's FFO reconciliation table was not preserved in extraction, and on the measures that ARE computable — roughly 53 times trailing operating cash flow per share, 13.2 times sales, 122 times GAAP earnings — the stock is expensive on every one."
- What we’re watching
- "The 2026-10-26 print, and specifically whether the per-share figure the vendor tracks can be reconciled to a stated funds-from-operations number — the last three quarters produced $1.13 against a $0.59 estimate, $1.02 against $0.679 and $0.61 against $0.617, a pattern too erratic to be a single consistent measure. Whether the more-than-$5 billion of second-half seniors-housing acquisitions closes, and how it is funded — equity issuance would extend a share count already up 21.1% in two years. Same-store net operating income in the Seniors Housing Operating segment, which the 10-Q reports across 980 same-store properties and which is the cleanest read on whether the operating model is working. And whether the 50-day average at $224.58 holds; it is 3.0% below."
- Confidence
- Low
Medium term 6-24 months
Tailwind- Driver
- "The medium term is the acquisition machine converting into occupancy and rate. Seniors Housing Operating revenue grew 40.7% in 2025 to $8.489 billion and is 79.6% of the company; the June 2026 quarter grew total revenue 40.9%; and the 10-Q discloses more than $5 billion of further acquisitions closing or expected to close in the second half of 2026 alone. Consensus takes revenue to $14.053 billion, $15.916 billion and $18.109 billion over the next three years. Because the segment is OPERATING rather than triple-net, Welltower captures the margin on occupancy and rate increases rather than a fixed rent, and the seniors-housing supply picture is favourable — construction has been constrained and the 10-Q reports construction conversions of $257.4 million at $450,080 per unit in the first half, a cost basis that new supply would struggle to match. Impairments are minimal at $27.2 million on 12 properties in the half. The balance sheet supports more: net debt of $16.347 billion against $43.203 billion of equity is 0.425x."
- What we’re watching
- "The share count above all. It went from 604.6 million to 732.1 million in two years and every acquisition dollar not funded with debt extends it. Per-share growth is what a holder receives and it is materially slower than the 40% revenue line. Whether the operating model holds: Seniors Housing Operating carries staffing cost and occupancy risk that a triple-net lease does not, and 79.6% of revenue now sits there. Whether the acquisition pipeline stays disciplined — more than $5 billion in one half is a fast pace and the 10-Q itself notes the transactions are 'subject to customary closing conditions and regulatory approvals'. Whether the dividend, at $0.85 a quarter and a 1.47% forward yield, rises toward a level a REIT investor would recognise, or whether retained cash keeps funding growth instead. And whether a funds-from-operations figure becomes available in a form we can verify."
- Confidence
- Low
Long term 2+ years
Tailwind- Driver
- "The long-run case is demographic and it does not require much argument. Welltower owns and increasingly operates seniors housing in three markets — the United States ($7.937 billion of 2025 revenue), the United Kingdom ($2.167 billion) and Canada ($734 million) — all of which face a sharp increase in the eighty-plus population this decade against a housing stock that has barely grown because construction financing tightened for most of the 2020s. Fixed supply meeting rising demand is the most durable setup an asset owner can have. Welltower has also chosen the operating rather than the leasing side of it, which means it captures rate and occupancy gains directly. The balance sheet is unusually clean for the sector: $67.303 billion of total assets with ZERO goodwill and ZERO intangibles, and a 0.425x debt-to-equity ratio. And the dividend record — the 221st consecutive quarterly payment falls due 2026-08-20 — is the kind of continuity that survives cycles."
- What we’re watching
- "Whether new supply arrives. The entire thesis is constrained supply meeting rising demand, and construction economics of roughly $450,000 per unit are the barrier; if financing loosens, that barrier falls. Whether the operating model survives a labour-cost shock — seniors housing is staffing-intensive and Welltower now takes that risk directly on 79.6% of its revenue. Whether the share count compounds faster than the asset base, which is the central risk in any externally-funded REIT and which the data here cannot resolve without an FFO-per-share series. Whether the 1.28% dividend yield eventually converges toward the sector's historical 4-6%, which would require either a much larger dividend or a much lower price. Management succession: Shankh Mitra has led the company since 2020 and the file contains no succession disclosure. The company has 712 employees against $67.3 billion of assets, which is a very small team for this scale of transaction activity."
- Confidence
- Low
Exponential Potential
"Rated 5 — a genuine demographic slope expressed through a capital-intensive, share-issuing vehicle. The eighty-plus population in the United States, the United Kingdom and Canada — Welltower's three disclosed markets at $7.937 billion, $2.167 billion and $734 million of 2025 revenue — inflects sharply this decade, and seniors-housing supply has been structurally constrained since construction financing tightened. That is a multi-decade demand curve meeting a fixed asset base, which is the best possible setup for an owner. Welltower is also consolidating operators rather than merely landlording: the Seniors Housing OPERATING segment is 79.6% of revenue, meaning the company captures the operating margin rather than a fixed rent, which is where the upside lives if occupancy and rate both rise. Against that, capturing a demographic slope through a REIT requires continuous equity issuance — 21.1% in two years — so the per-share compounding is a fraction of the asset-level compounding, and the vehicle cannot escape that. There is also no knowledge-base corroboration of any kind: zero claims across 51,928 on this name, this sector or this thesis. A 5: a real slope, an inefficient wrapper, and no external validation available to us."
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
> MEASUREMENT WARNING. Welltower is a REIT. Funds from operations, not earnings per share, is the measure the sector is valued on. The vendor payload contains NO FFO field. The 10-Q filed 2026-07-28 DOES carry the FFO-to-net-income reconciliation — we located it — but the WELL filing archive is flagged tables: false, so the table was not preserved in extraction and NO FFO FIGURE IS AVAILABLE TO US. This dive therefore values Welltower on operating cash flow, revenue and the dividend, and its precision is materially lower than the other eleven names in this batch. We state that rather than substituting a number we cannot source.
| Street consensus | $251.83 (+8.8%) · median $257 · high $275 · low $215, 7.2% below spot · 1 strong buy / 24 buy / 10 hold / 0 sell across 35 analysts |
| Valuation | ~53x trailing operating cash flow per share · 13.2x sales · 122.5x trailing GAAP EPS (a depreciation artefact — rejected) · P/B 3.52x · NO FFO MULTIPLE AVAILABLE |
| Balance sheet | Net debt $16.347B against total equity of $43.203B — debt/equity 0.425x, genuinely conservative for a REIT. ZERO goodwill and ZERO intangibles on $67.303B of assets. Cash $5.034B. The balance sheet is seven months old at a moment when the company is transacting at $5B a half |
| Growth | Revenue +35.8% in 2025 to $10.667B and +40.9% in the June quarter; Seniors Housing Operating +40.7% to $8.489B (79.6% of revenue); more than $5 BILLION of further acquisitions closing or expected to close in the second half of 2026 (10-Q, no vendor field) |
| Dilution | Diluted shares 604.6M (Q2 2024) → 732.1M (Q2 2026) — +21.1% in two years |
| Conviction | NONE — ZERO raw hits. No entity claims and no text claims across 51,928 on Welltower, senior housing, seniors housing or healthcare REITs. The only completely empty lane in this batch |
| Technicals | −8.1% from the 52-week high of $252.07, +43.1% above the low of $161.88, 77th percentile; +3.1% above the 50-DMA and +13.1% above the 200-DMA, both rising; RSI 47.9; MACD +2.80; 12-month +39.3% vs SPY +24.3% — the best in this batch |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for WELL — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $238.07, 1% above the 50-day average ($235), 13% above the 200-day average ($210) — an uptrend. 6% below the 52-week high of $252, 44% above the 52-week low of $165.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $238.07 is currently inside the band (band $229–$243).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 53.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently above its signal line by 0.22, positive momentum.
Relative performance vs S&P 500 & its sector (XLRE (sector)), set to 100 a year ago
Solid = WELL · dashed = S&P 500 · dotted = XLRE (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What the business is
Chief executive Shankh S. Mitra; 712 employees — a remarkably small team for $67.3 billion of assets and a $5 billion half-year acquisition programme; NYSE-listed; reporting in USD.
Three segments, and seg_prod nearly ties. The three fiscal-2025 lines sum to $10,468M against reported revenue of $10,667M — a $199M (1.9%) residual.
| Segment | FY2025 | Share | FY2024 | Growth | FY2023 |
|---|---|---|---|---|---|
| Seniors Housing Operating | $8,489M | 79.6% | $6,035M | +40.7% | $4,774M |
| Triple Net | $1,197M | 11.2% | $789M | +51.8% | — |
| Outpatient Medical | $782M | 7.3% | $802M | −2.5% | — |
| Total | $10,468M | $7,626M | +37.3% | — | |
| Reported revenue | $10,667M | $7,854M | +35.8% | $6,478M |
Seniors Housing OPERATING at 79.6% of revenue is the single most important structural fact about this company and it is often misunderstood. In a triple-net lease the REIT collects a fixed rent and the operator takes the business risk. In an operating structure, Welltower consolidates the property's revenues and expenses — so it captures the upside when occupancy and rate rise, and it wears the staffing and cost risk when they do not. That is why revenue can grow 40% and why the operating margin is volatile.
seg_geo ties cleanly. United States $7,937M + United Kingdom $2,167M + Canada $734M = $10,838M against reported revenue of $10,667M — a 1.6% over-sum, which is within the tolerance created by intersegment and unconsolidated presentation. The United Kingdom at 20.3% of revenue is unusually large for a US-listed healthcare REIT and is not reflected in any commentary in this file.
The acquisition programme, from the 10-Q filed 2026-07-28 — no vendor field contains it:
> "In July 2026, we announced that we have closed or expect to close more than $5 billion of seniors housing acquisitions in the second half of the year. Expected acquisitions not yet closed are subject to customary closing conditions and regulatory approvals."
More than $5 billion in one half, against a $166.9 billion market capitalisation and total assets of $67.3 billion. That is a roughly 7.4% expansion of the asset base in six months, on top of a 35.8% revenue increase in the prior year.
Two further filing disclosures with no vendor equivalent. Construction conversions in the first half were $257,446,000 at $450,080 per unit — the replacement cost that constitutes the supply barrier. And impairments were $27,181,000 on 12 properties in the first half of 2026, down from $33.8 million a year earlier — very small against a $67.3 billion asset base, and a genuine sign of portfolio health.
Same-store net operating income is disclosed by segment across 980 same-store Seniors Housing Operating properties, 499 triple-net properties and a further pool in Outpatient Medical. The figures themselves sit in tables that were not preserved in extraction, so we can confirm the disclosure exists and cannot report the numbers.
2. Growth, and the dilution that pays for it
| Fiscal year | Revenue | YoY | Operating income | Net income | Diluted shares | Revenue per share |
|---|---|---|---|---|---|---|
| 2020 | $4,587M | — | $727M | $979M | 417.4M | $10.99 |
| 2021 | $4,709M | +2.7% | $763M | $336M | 426.8M | $11.03 |
| 2022 | $5,776M | +22.7% | $746M | $141M | 465.2M | $12.42 |
| 2023 | $6,478M | +12.2% | $940M | $340M | 518.7M | $12.49 |
| 2024 | $7,854M | +21.2% | $1,146M | $952M | 608.8M | $12.90 |
| 2025 | $10,667M | +35.8% | $355M | $937M | 679.5M | $15.70 |
Revenue per share is the honest growth measure for an externally-funded REIT and it is materially slower than the headline: $10.99 to $15.70 over five years, 7.4% compound, against total revenue compounding at 18.4%. Roughly 11 points of the 18.4% went to new shareholders. That is not a criticism — it is how the model works, and 7.4% per-share revenue growth is still good — but it is the number a holder actually receives, and it is the number no screen shows.
The dilution is accelerating. Diluted shares: 604.6M (Q2 2024) → 653.8M → 668.1M → 685.4M → 710.2M → 726.3M → 732.1M (Q2 2026) — +21.1% in two years.
| Quarter | Revenue | YoY | Operating income | Net income | Per-share figure (earn_cal) | vs estimate |
|---|---|---|---|---|---|---|
| Q2 2025 | $2,516M | — | $443M | $302M | — | — |
| Q3 2025 | $2,628M | +30.7% | $477M | $281M | — | — |
| Q4 2025 | $3,134M | +41.2% | ($944M) | $96M | $1.13 | vs $0.59 |
| Q1 2026 | $3,306M | +38.4% | $558M | $729M | $1.02 | vs $0.679 |
| Q2 2026 | $3,545M | +40.9% | $589M | $240M | $0.61 | vs $0.617 — in line |
Three consecutive quarters above 38% revenue growth, and the June quarter beat the $3,403M revenue consensus by 4.2%.
Two problems in this table that we flag rather than explain. First, the December 2025 quarter shows an operating LOSS of $943.7M on revenue of $3,134M while net income was positive at $96.4M — a swing no document in this archive accounts for. Second, the earn_cal per-share series is not a consistent measure: $1.13 against a $0.59 estimate, $1.02 against $0.679, then $0.61 against $0.617. Computed GAAP EPS for those quarters is $0.136, $1.003 and $0.328 — matching only the middle one. We therefore do not use the earn_cal per-share series for anything, and we say so.
3. Balance sheet, and what the vendor cannot describe
| 2025-12-31 | |
|---|---|
| Cash and equivalents | $5,034M |
| Short-term investments | $0 |
| Total assets | $67,303M |
| Goodwill | $0 |
| Intangible assets | $0 |
| Property, plant and equipment, net | $2,158M |
| Long-term investments | $1,810M |
| Long-term debt | $19,197M |
| Capital lease obligations | $2,183M |
| Total debt | $21,380M |
| Net debt | $16,347M |
| Total liabilities | $24,100M |
| Total stockholders' equity | $42,129M |
| Noncontrolling interests | $1,073M |
| Total equity | $43,203M |
Correction 1 — propertyPlantEquipmentNet of $2,158M against $67,303M of total assets is not a usable description of a REIT. Welltower's business is owning buildings. The vendor's PP&E line captures 3.2% of the asset base; the real-estate investments are evidently mapped to other line items the payload does not surface. No asset-composition conclusion in this dive uses the vendor's balance-sheet classification. What we can say from it, and it is genuinely creditable, is that goodwill and intangibles are BOTH ZERO — Welltower carries no acquisition premium at all on $67.3 billion of assets, which is rare and is a real quality signal.
Correction 2 — netDebt is arithmetically correct at its own date and the date is the problem. Welltower carries $0 of short-term investments, so the standard omission cannot occur: $21,380M less $5,034M = $16,347M. This is one of only three names in this batch where that field needed no construction repair. But the balance sheet is 2025-12-31, and the company has since disclosed more than $5 billion of second-half acquisitions on top of whatever closed in the first half. There is no filing-verified balance sheet later than 2026-06-30 available in extracted form, because the WELL archive preserved no tables.
Correction 3 — interestCoverageRatioTTM of 0.92x is a depreciation artefact and is REJECTED. It is computed on GAAP operating income of $355M against interest expense of $652M. But depreciation and amortisation was $2,139M in 2025 — six times operating income — and for a property company that charge is largely non-economic. Adding it back gives roughly $2.5 billion against $652M of interest, or 3.8x coverage. The vendor's 0.92x would, at face value, describe a company unable to pay its interest; Welltower generated $2,882M of operating cash flow in the same year. We reject the field.
Correction 4 — priceToEarningsDilutedRatioTTM of 122.5x, returnOnEquityTTM of 3.15%, returnOnInvestedCapitalTTM of 0.96% and dividendPayoutRatioTTM of 152.4% are all the same artefact and are all REJECTED. They divide by a GAAP net income that depreciation has crushed. For a REIT these fields are not merely unhelpful, they are actively misleading, and the vendor's own composite rating scores WELL 1 out of 5 on both price-to-earnings and price-to-book as a direct result, dragging it to B− / 3. We reject the composite.
What the balance sheet does support, on any reading: debt-to-equity of 0.425x, $5.034B of cash, zero goodwill, and impairments of $27.2M on 12 properties in the first half against $67.3B of assets. This is a conservatively financed property company.
4. Cash flow and the dividend
| Year | Operating cash flow | Capex | Free cash flow | Dividends paid | D&A |
|---|---|---|---|---|---|
| 2022 | $1,329M | $30M | $1,298M | $1,132M | $1,337M |
| 2023 | $1,602M | $51M | $1,551M | $1,261M | $1,401M |
| 2024 | $2,256M | $58M | $2,198M | $1,545M | $1,680M |
| 2025 | $2,882M | $34M | $2,848M | $1,878M | $2,139M |
Operating cash flow more than doubled in three years, from $1,329M to $2,882M, and reported capital expenditure is trivial at $34M — because for a REIT the capital goes out through the investing line as property acquisitions, not through maintenance capex. The freeCashFlow figure of $2,848M is therefore NOT free cash flow in any economically meaningful sense and neither is priceToFreeCashFlowRatioTTM of 53.5x. We use operating cash flow and say what it is.
Trailing operating cash flow is approximately $3,200M (derived from priceToOperatingCashFlowRatioTTM of 52.15 against the market capitalisation), or $4.37 per diluted share on 732.1M shares — a price-to-operating-cash-flow-per-share of roughly 53x.
For context, healthcare REITs have historically traded at 15-25x funds from operations. Operating cash flow is not FFO — it includes working-capital movements and excludes some FFO adjustments — but a 53x multiple on the closest computable proxy is high on any interpretation, and we report it as the best available measure while stating its limitations.
The dividend, from the filing. The 10-Q: "On July 27, 2026, our Board of Directors declared a cash dividend for the quarter ended June 30, 2026 of $0.85 per share. On August 20, 2026, we will pay our 221st consecutive quarterly cash dividend."
The forward run-rate is therefore $3.40 — a 1.47% yield. The vendor's lastDividend and dividendPerShareTTM of $2.96 are the trailing-twelve-month total, implying 1.28% — the same mislabelling seen across this batch, and here the gap between trailing and forward is 15%, reflecting a rising dividend.
A 1.28-1.47% yield is very low for a healthcare REIT. The sector has historically yielded 4-6%. Welltower's yield is where it is because the price has risen 39.3% in twelve months and because the company retains cash to fund acquisitions rather than distributing it. That is a defensible growth choice and it means this security does not perform the function most REIT buyers want from the asset class.
5. Valuation — and the honest limits of it
At $231.57 (market capitalisation $166.863B; enterprise value approximately $183.2B on market cap plus net debt of $16.347B):
| Trailing | FY2026E | FY2027E | FY2028E | |
|---|---|---|---|---|
| Revenue | $12.585B (TTM) | $14.053B (3 analysts) | $15.916B (6) | $18.109B (4) |
| Revenue growth | — | +31.7% (on FY2025's $10.667B) | +13.3% | +13.8% |
| Price / sales | 13.2x | 11.9x | 10.5x | 9.2x |
| Price / operating cash flow per share | ~53x | — | — | — |
| Price / book | 3.52x | — | — | — |
| P/E on trailing GAAP | 122.5x — REJECTED | — | — | — |
| Consensus per-share figure (basis unverified) | — | $2.849 (5) | $3.199 (5) | $4.046 (5) |
| Implied multiple on that figure | — | 81.3x | 72.4x | 57.2x |
| Dividend yield | 1.28% trailing / 1.47% forward | — | — | — |
| Net debt / equity | 0.378x | — | — | — |
The consensus per-share series cannot be identified and no conclusion rests on it. est.epsAvg for fiscal 2025 is $1.826, against computed GAAP diluted EPS of $1.379 — so it is not GAAP. It is also far too low to be funds from operations for a company generating $2,882M of operating cash flow on 679.5M shares ($4.24 per share). It is neither, and the implied forward multiples of 81x, 72x and 57x are not interpretable on any basis. We report the series, state that its basis is unverified, and do not use it to set fair value.
est.ebitdaAvg and est.ebitAvg carry the fixed-ratio fabrication signature and are REJECTED. ebitdaAvg / revenueAvg = 33.16% and ebitAvg / revenueAvg = 11.32% in all eight years, to four significant figures. Actual fiscal-2025 EBITDA was $2,310M on $10,667M — 21.7%, and actual operating margin 3.3%.
Estimate coverage is the thinnest in this batch and it disqualifies the far years entirely. FIVE analysts on the per-share line in every year from 2026 to 2028, THREE on 2026 revenue, and ONE analyst on both the 2029 and 2030 per-share lines. The fiscal-2030 revenue line of $29.988B against fiscal-2029's $18.296B is a 63.9% single-year jump on three analysts and is self-evidently unusable. Fiscal 2029 and 2030 are excluded entirely.
Peer context. The vendor peer set mixes property types: American Tower, Digital Realty, Equinix and Prologis are towers, data centres and logistics — not healthcare comparables. The genuine peers are Ventas (VTR), National Health Investors, LTC Properties, Global Medical REIT and Universal Health Realty — of which Ventas is the only one of comparable scale. No peer multiples are supplied in the file, so no peer-multiple comparison is drawn — which is a material loss on this name, because relative funds-from-operations multiples are the standard way the sector is valued and we have neither the multiple nor the peer.
5a. What today's price assumes (the inversion)
At $231.57 — roughly 53x trailing operating cash flow per share and 13.2x sales — the price embeds:
- Revenue reaches $14.053B in 2026 (+31.7%) and $15.916B in 2027. (Consensus; only 3 and 6 analysts.) The near check is 2026-10-26 at $3.580B, +36.2% year on year. The June quarter delivered +40.9%, so the run-rate supports it.
- More than $5 billion of second-half acquisitions closes and performs. (10-Q disclosure; our framing.) This is the most fragile assumption in the price, because it is 7.4% of the asset base in six months and the filing itself notes the transactions are "subject to customary closing conditions and regulatory approvals."
- The Seniors Housing Operating model captures occupancy and rate gains. (Filing structure.) 79.6% of revenue sits in an operating rather than leased structure, so the margin is Welltower's to win or lose. The same-store net operating income disclosure across 980 properties is the read on this and it is in a table we could not extract.
- Dilution stays proportionate to asset growth. (Our framing.) Revenue per share compounded 7.4% over five years while total revenue compounded 18.4% — roughly 11 points a year went to new shareholders. If the next $5 billion is funded with equity at these prices, the arithmetic is favourable; at a lower share price it is not, which is the reflexive risk in every externally-funded REIT.
- The market keeps paying roughly 50x operating cash flow. (Our number.) At 40x the stock is $175; at 60x it is $262. We have no historical multiple series with which to calibrate this, and we say so.
5b. The return bridge (why the multiple moves)
We cannot construct a conventional return bridge for this name and will not pretend otherwise. The decomposition requires an earnings-per-share series, and there is none available: the GAAP figure is a depreciation artefact, the consensus figure has an unverifiable basis, and funds from operations — the correct measure — is not obtainable from either source in this archive.
What we can say. Over roughly two years: revenue per share grows at perhaps 8-12% (13.3% consensus revenue growth in 2027 less continued dilution), the dividend contributes 1.3-1.5% a year, and the multiple is the entire remaining variable and we have no basis for forecasting it. On that arithmetic the expected return is roughly 10-14% a year IF the multiple holds, and materially negative if it does not.
Our base assumes the multiple HOLDS, which is the only defensible assumption when we cannot measure it. The bear case at $185 assumes it compresses to roughly 42x operating cash flow — which would put the stock near its 200-day average of $204.77 with an overshoot, and 14% above the 52-week low. The bull case at $280 assumes revenue growth of 13-14% is sustained and the multiple expands modestly, and sits above the street's $275 high.
This is the least rigorous fair-value construction in this batch and it is labelled as such at every point of use.
5c. Variant perception (where we differ, what would surprise)
- Our principal variant view is a measurement claim rather than a valuation one, and it is the most important thing in this dive. Welltower is a REIT and no funds-from-operations figure is available from the vendor payload or from the extracted filings. The 10-Q filed 2026-07-28 contains the reconciliation — we located the section — but the WELL archive preserved no tables. Every headline multiple on every screen for this name (122.5x earnings, 152.4% payout, 0.92x interest coverage, 0.96% return on invested capital) is a depreciation artefact and is wrong as a description of the business. We reject all of them, publish the computable alternatives, and state the loss of precision.
- We think the share count is the under-discussed variable. Revenue compounded 18.4% over five years; revenue PER SHARE compounded 7.4%. Roughly 11 points a year went to new shareholders. That is the REIT model working as designed, and it is also the reason headline growth of 40.9% should not be read as a per-share number. Watchable number: diluted shares in the 2026-10-26 filing against 732.1M, alongside whatever the more-than-$5-billion acquisition programme costs.
- We think the balance sheet is better than the sector's reputation and the vendor's rating. Zero goodwill and zero intangibles on $67.3 billion of assets; 0.425x debt-to-equity; $5.034 billion of cash; $27.2 million of first-half impairments on 12 properties. The vendor's B− / 3 rating with 1-out-of-5 scores on price-to-earnings and price-to-book is measuring depreciation, not credit.
- We have no external validation of any kind and it matters more here than anywhere else in this batch. Zero knowledge-base claims — not one, on the company, the sector or the demographic thesis. On a name where the primary data source cannot supply the industry-standard earnings measure, the absence of any independent view is a compounding problem rather than a separate one.
- Positive surprise that would force a re-rate: the more-than-$5-billion acquisition programme closing at disclosed yields with debt rather than equity funding; same-store net operating income growth in Seniors Housing Operating accelerating; a dividend increase materially above the $0.85 quarterly rate; or simply an FFO figure becoming available in a form we can verify, which would let us value the company properly.
- Negative surprise that would break the thesis: an equity issuance materially larger than the acquisition programme requires; occupancy or staffing-cost deterioration in the operating segment, which carries the risk a triple-net lease does not; the acquisition pipeline failing regulatory conditions; or impairments rising materially from the current $27.2 million. At 53x operating cash flow and a 1.28% yield there is no income cushion under this price.
Synthos fair values
These anchors are built on price-to-operating-cash-flow-per-share and price-to-sales, because no funds-from-operations figure is available. They are materially less precise than the anchors in the other eleven dives in this batch and should be read accordingly.
- Bear ~$185 — roughly 42x trailing operating cash flow per share and 8.5x fiscal-2027 consensus revenue. Cross-check: 9.6% below the 200-day average of $204.77 and 14.3% above the 52-week low of $161.88. The scenario: the acquisition programme stalls on closing conditions, seniors-housing occupancy or staffing costs deteriorate in the 79.6% of revenue that is operating rather than leased, dilution outpaces asset growth, and the multiple compresses toward something a 1.5%-yielding REIT can support. −20.1%.
- Base ~$232 — roughly 53x trailing operating cash flow per share held, 13.2x trailing sales, 10.5x fiscal-2027 consensus revenue, 3.52x book. Sensitivity, stated openly: 45x operating cash flow gives $197, 15% BELOW spot; 60x gives $262, above the street's median. The whole answer lives in a 45-60x band on a proxy measure, and we claim no more precision than that — this is the widest honest uncertainty in the batch. The scenario: revenue compounds at the consensus 13% while dilution runs at 5-8%, giving mid-to-high-single-digit per-share growth, the dividend adds 1.5%, and the multiple holds. +0.2%.
- Bull ~$280 — roughly 60x operating cash flow on a base grown by the disclosed acquisitions, and 8.9x fiscal-2028 consensus revenue. Above the street's $275 high and disclosed as such. The scenario: the demographic wave arrives faster than supply can respond, the operating model captures both occupancy and rate, the $5 billion pipeline is accretive, and Welltower re-rates as the consolidator of a fragmented industry. +20.9%.
Base is essentially at spot (+0.2%); asymmetry roughly 1.04:1 — symmetric. That is the least attractive setup in this batch, and it is compounded by the fact that our own confidence in these numbers is the lowest here. What holds this at Watch rather than anything more definite is exactly that: a genuinely excellent operating story that we cannot price, at a price 7.9% below where the street thinks it should be, with zero independent corroboration.
6. Knowledge base — zero claims
Raw hits: 0. Entity matches: 0. Text matches: 0.
Searches covered Welltower, senior housing, seniors housing and healthcare REIT across all 51,928 distilled claims. Not one claim names this company, this sector, or the seniors-housing demographic thesis in any form.
This is the only completely empty lane in this batch and it is stated as a finding rather than padded. We could have reached for adjacent real-estate or demographic commentary; there is none that names Welltower and none that addresses healthcare property, and manufacturing a lane from unrelated material would be dishonest.
The consequence is worth naming precisely. On every other name in this batch, the knowledge base has provided at least one of three things: an independent structural claim we could test against the filings, a dated forecast we could adjudicate, or a bearish counterweight to the vendor's framing. Here it provides none. Combined with the absence of a funds-from-operations figure, Welltower is the name in this batch where the Synthos process has the least to say — and the honest response is to lower the confidence rather than to raise the conviction.
Conviction: None. Breadth 0. Net conviction: none.
7. Data integrity — what we rejected from the vendor file and why
Nine findings. WELL's file is not so much defective as structurally unsuited to a REIT, and the filings archive compounds it.
1. There is NO funds-from-operations figure anywhere available — the central finding. FFO is the measure REITs are valued on. The vendor payload contains no FFO field of any kind. The 10-Q filed 2026-07-28 DOES contain it — the document states "The tables below reflect the reconciliation of FFO to NICS, the most directly comparable U.S. GAAP measure, for the periods presented" — but the WELL archive is flagged tables: false in the filings index and the table was not preserved in extraction. We therefore have no FFO figure, no FFO-per-share figure and no FFO multiple, and every valuation conclusion in this dive is built on proxies with the loss of precision stated. The same extraction loss removes the same-store net operating income tables, the EBITDA and Adjusted EBITDA reconciliations, and the leverage-ratio table.
2. priceToEarningsDilutedRatioTTM of 122.5x, returnOnEquityTTM of 3.15%, returnOnInvestedCapitalTTM of 0.96%, dividendPayoutRatioTTM of 152.4% and interestCoverageRatioTTM of 0.92x are all the same depreciation artefact — ALL REJECTED. Depreciation and amortisation was $2,139M in 2025 against operating income of $355M — six times. For a property company that charge is largely non-economic, which is precisely why the industry uses FFO. Adding D&A back gives interest coverage of roughly 3.8x rather than 0.92x. The vendor's composite rating of B− / 3 with 1-out-of-5 scores on price-to-earnings and price-to-book is the same artefact propagated into a grade, and it is rejected too.
3. propertyPlantEquipmentNet of $2,158M against $67,303M of total assets is not a usable description. Welltower's business is owning real estate; the vendor's PP&E line captures 3.2% of the asset base. No asset-composition conclusion uses the vendor's classification. What IS usable and creditable: goodwill and intangibleAssets are both ZERO, meaning Welltower carries no acquisition premium at all — a genuine and unusual quality signal that the payload does report correctly.
4. epsdiluted is NULL in every income-statement row — annual and quarterly. All six annual and all nine quarterly rows. This is the FIFTH instance in this batch (with UNP, QCOM, DIS and GILD) and it now looks systematic across the vendor's coverage rather than name-specific. Every EPS figure here is computed.
5. The earn_cal per-share series is not a consistent measure and is NOT USED. Reported actuals of $1.13 (against a $0.59 estimate), $1.02 (against $0.679) and $0.61 (against $0.617) compare with computed GAAP diluted EPS for the same quarters of $0.136, $1.003 and $0.328 — matching only the middle one. The series is internally inconsistent and no conclusion in this dive rests on it.
6. est.epsAvg has an unverifiable basis and is NOT USED to set fair value. The fiscal-2025 row of $1.826 is neither computed GAAP diluted EPS ($1.379) nor a plausible funds-from-operations figure for a company generating $2,882M of operating cash flow on 679.5M shares ($4.24 per share). The implied forward multiples of 81x, 72x and 57x are not interpretable on any basis. We report the series with the basis flagged as unverified and anchor fair value on operating cash flow and revenue instead.
7. est.ebitdaAvg and est.ebitAvg carry the fixed-ratio fabrication signature — REJECTED. ebitdaAvg / revenueAvg = 33.16% and ebitAvg / revenueAvg = 11.32% in all eight years, to four significant figures. Actual fiscal-2025 EBITDA was 21.7% of revenue and actual operating margin 3.3%.
8. Estimate coverage is the thinnest in this batch and the far years are excluded. FIVE analysts on the per-share line for 2026, 2027 and 2028; THREE on 2026 revenue; and ONE analyst on both the 2029 and 2030 per-share lines. The fiscal-2030 revenue estimate of $29.988B against fiscal-2029's $18.296B is a 63.9% single-year jump on three analysts. Fiscal 2029 and 2030 are excluded entirely.
9. lastDividend: 2.96 is the trailing-twelve-month total — corrected from the filing. The 10-Q: "On July 27, 2026, our Board of Directors declared a cash dividend for the quarter ended June 30, 2026 of $0.85 per share. On August 20, 2026, we will pay our 221st consecutive quarterly cash dividend." The forward run-rate is $3.40 — a 1.47% yield, against the 1.28% the field implies. A 15% gap, the largest such correction in this batch, reflecting a rising dividend.
netDebt is arithmetically correct at its own date — one of only three clean instances in this batch. Welltower carries $0 of short-term investments so the standard omission cannot occur: $21,380M less $5,034M = $16,347M. The limitation is staleness: the balance sheet is 2025-12-31 and the company has disclosed more than $5 billion of second-half acquisitions.
seg_prod and seg_geo both tie within tolerance. Segments sum to $10,468M against $10,667M (1.9% residual for unallocated); geography sums to $10,838M against $10,667M (1.6% over-sum, within intersegment tolerance). Both are usable.
An unexplained item: the December 2025 quarter shows an operating LOSS of $943.7M on revenue of $3,134M, with positive net income of $96.4M. No document in this archive accounts for it and we flag it rather than explaining it.
Share count — a 1.6% discrepancy, noted. Market cap of $166,862,860,587 divided by $231.57 gives 720,570,000, against a June-quarter diluted weighted average of 732.1M. The gap is consistent with the normal outstanding-versus-diluted wedge plus continuing issuance during the quarter, and is not treated as a defect.
quote.yearHigh/yearLow ($255.20 / $161.26) disagree with tech.hi52/lo52 ($252.07 / $161.88) by 1.2% and 0.4%. We use tech.
Non-equity tripwire — checked and passed. WELL is NYSE-listed common stock of a real estate investment trust. Price $231.57 is not par-like; beta 0.763; the dividend is variable and has just been declared at $0.85, the 221st consecutive quarterly payment; volume 4.62M shares (~$1.07B of turnover); the 52-week band of $161.88 to $252.07 is a 56% range. This is common equity. REIT structural note: distributions are largely taxed as ordinary income rather than qualified dividends, which is a material after-tax consideration for a taxable holder and which no field in this payload reflects.
8. Technicals
- Price $231.57. −8.1% from the 52-week high of $252.07; +43.1% above the low of $161.88. Position within the annual range: 77th percentile.
- Moving averages, both below and both rising: +3.1% above a 50-day of $224.58 and +13.1% above a 200-day of $204.77. A clean uptrend.
- RSI 47.9 — neutral, having cooled from the highs. MACD +2.80 — positive.
- Maximum drawdown from peak over the trailing year: −8.1% — shallow.
- Relative performance — the best in this batch: 3-month +6.6% vs SPY +7.6%; 6-month +23.6% vs SPY +11.1% and QQQ +15.7%; 12-month +39.3% vs SPY +24.3% and QQQ +30.8%. A fifteen-point twelve-month outperformance of the index and an eight-point outperformance of the technology index — by a REIT.
- Sentiment: 1 strong buy, 24 buy, 10 hold, 0 sell across 35 analysts. Consensus $251.83 (+8.8%), median $257, high $275 (+18.8%), low $215 (−7.2%).
Today's move and the entry
WELL closed 2026-08-04 at $231.57, DOWN 0.66% or $1.53 from $233.10, on 4.62M shares in a $226.48–$232.16 range. It opened at $230.31 and closed near the day's high after touching $226.48 — an intraday recovery. One of only two declines among the twelve names in this batch on this date. No company-specific news appears in this file for 2026-08-04; the last event was the 2026-07-27 second-quarter release eight days earlier, which beat on revenue by 4.2%.
The honest read. The chart is strong, the growth is the fastest in the batch, and the price is at the 77th percentile after a 39.3% year. On every measure we can compute the stock is expensive, and the measure the market actually uses is unavailable to us. That combination — a good business, a high price, and an unmeasurable one — is exactly what a Watch is for.
What would change the answer:
- A price near $195 — roughly 45x operating cash flow per share, close to the 200-day average of $204.77 — which would put our $232 base at +19%. That is 16% below today's close.
- Or a verifiable funds-from-operations figure, which would let us value this company on the sector's own terms and replace the widest fair-value uncertainty in this batch with an ordinary one. That is a documentation event, not a market one, and it is the single most useful thing that could happen to this dive.
9. Insiders
The insider file contains no material open-market activity in either direction and is reported as neutral. There are no open-market purchases and no discretionary open-market sales of size. With the stock up 39.3% over twelve months and at the 77th percentile of its range, the absence of insider selling is a mild positive and no more than that.
The economically significant capital action is the issuance, and it is not in the Form 4s. The diluted share count rose from 604.6 million to 732.1 million in two years — 21.1% — funding an acquisition programme that added 35.8% to revenue in 2025 and is disclosed as adding more than $5 billion of further assets in the second half of 2026. A holder's return depends entirely on whether the assets bought compound faster than the shares issued to buy them, and that is the calculation this dive cannot complete without a funds-from-operations series.
10. Verdict, kill-criteria and flip conditions
Watch — with the lowest confidence in this batch, stated as such.
What is genuinely strong: the fastest revenue growth here by a wide margin — +35.8% in 2025 and +40.9% in the June quarter, with Seniors Housing Operating up 40.7% to $8.489 billion; a 4.2% revenue beat in the most recent print; more than $5 billion of further seniors-housing acquisitions closing or expected to close in the second half of 2026; a genuine multi-decade demographic driver meeting a supply base constrained by a $450,080-per-unit replacement cost; a balance sheet with ZERO goodwill and ZERO intangibles on $67.3 billion of assets and 0.425x debt-to-equity; impairments of just $27.2 million on 12 properties in the half; the 221st consecutive quarterly dividend; operating cash flow more than doubled in three years; and a 12-month return of +39.3%, the best in this batch.
What we are declining to underwrite: a 21.1% increase in the diluted share count over two years, which reduces 18.4% five-year revenue compounding to 7.4% per share; a valuation of roughly 53x trailing operating cash flow per share, 13.2x sales and 3.52x book with a 1.28% trailing dividend yield in a sector that historically yields 4-6%; NO funds-from-operations figure available from any source, which is the measure the sector is valued on; five-analyst forward coverage with one analyst on the two furthest years; an unexplained $943.7 million operating loss in the December 2025 quarter; an earn_cal per-share series that is internally inconsistent; ZERO knowledge-base claims of any kind; and a base fair value of $232 that is essentially spot and 7.9% below the street's $251.83.
The distinction that matters. This is not a judgement that Welltower is a poor business — on the evidence available it is a very good one, growing faster than anything else in this batch, on a demographic driver that does not need to be argued, with the cleanest balance sheet here. It is that we cannot price it. The vendor cannot supply the industry-standard earnings measure, the filing that contains it lost the table in extraction, the consensus per-share series has an unverifiable basis, and the knowledge base is silent. In the Synthos frame, a name we cannot measure is a Watch by construction, and the honest response is to lower the confidence rather than to raise the conviction.
Pre-registered KILL criteria — what would take this to Avoid:
- An equity issuance materially larger than the disclosed acquisition programme requires, or dilution running ahead of asset growth for two consecutive quarters.
- Seniors Housing Operating same-store net operating income turning negative. It is 79.6% of revenue and it carries staffing and occupancy risk a triple-net lease does not.
- Impairments rising materially above the current $27.2 million half-year run-rate, which would suggest the acquisition pace has outrun the diligence.
- The more-than-$5-billion pipeline failing on the "customary closing conditions and regulatory approvals" the filing names.
- The dividend being held flat, which would signal that retained cash is required rather than chosen.
Pre-registered FLIP conditions — what would take this to Buy — Tactical:
- A verifiable funds-from-operations per-share figure becoming available, allowing the company to be valued on the sector's own terms. This is the single most useful development available and it is documentary rather than market-driven.
- Or a price near $195 (roughly 45x operating cash flow per share, near the 200-day average of $204.77). At $195 the base case is +19%. That is 16% below today's close.
- The second-half acquisition programme closing at disclosed yields and funded predominantly with debt rather than equity, which would break the dilution pattern.
- Same-store net operating income growth in Seniors Housing Operating accelerating, disclosed in a form we can read.
- A material dividend increase above the $0.85 quarterly rate, which would begin to restore the income function REIT holders expect.
Where WELL fits in the Synthos Framework Portfolio. The real-estate and demographic-infrastructure sleeve, at 0% today with a 1-1.5% target on a fill near $195 or on FFO becoming available. On batch overlap: WELL is the only REIT here and correlates with nothing else in the twelve; its 0.763 beta and property asset base make it a genuine diversifier. Note the tax structure: REIT distributions are largely ordinary income rather than qualified dividends, which is a material after-tax consideration no field in this payload reflects. Logged as a tracked Synthos call (Watch) as of 2026-08-04 at $231.57, with the explicit note that the confidence is the lowest in this batch and the limitation is documentary.
Single biggest risk: the share count. Diluted shares went from 604.6 million to 732.1 million in two years — 21.1% — and the company has disclosed more than $5 billion of further acquisitions for the second half of 2026. Total revenue compounded 18.4% over five years; revenue PER SHARE compounded 7.4%. Roughly eleven points a year went to new shareholders. That is the externally-funded REIT model working exactly as designed, and it is also why headline growth of 40.9% must not be read as a per-share number. The reflexive danger is specific: issuing equity at 53x operating cash flow to buy assets is accretive; issuing it at 30x is not, and the share price determines which. A large decline in the stock would therefore make the growth model itself more expensive, at the same moment as the multiple compressed.
Most fragile assumption in the price: that the multiple holds, because we cannot measure it. Every other assumption in this dive is a revenue or an asset assumption and both are observable quarterly. This one is a multiple assumption on a proxy measure — roughly 53x trailing operating cash flow per share — where the correct measure (funds from operations) is unavailable, the peer set contains no comparable multiple, and there is no historical series in this file with which to calibrate. If the right multiple is 45x rather than 53x, the stock is $197 — fifteen percent below today's price — and nothing about the business would have changed. That is an uncomfortable statement and it is the accurate one.
Provenance & disclosures
- Traceability: ZERO tagged knowledge-base claims name Welltower (raw hits 0; entity matches 0; text matches 0; breadth 0, net conviction none). Searches covered Welltower, senior housing, seniors housing and healthcare REIT across all 51,928 distilled claims and returned nothing on the company, the sector or the demographic thesis. This is the only completely empty lane in this batch and it is reported as a finding rather than padded with adjacent real-estate commentary. The consequence is stated plainly in Section 6: on every other name here the knowledge base supplied at least an independent structural claim, an adjudicable forecast, or a bearish counterweight; on Welltower it supplies none, and combined with the absence of a funds-from-operations figure this is the name in this batch where the Synthos process has least to say. No management voice and no promoter-class voice appears, because no voice appears at all.
- Data as-of: fundamentals — annual statements to 2025-12-31 from the vendor payload; quarterly income statement to 2026-06-30; most recent filing-verified NARRATIVE 2026-06-30, from the 10-Q filed 2026-07-28 — but see the extraction limitation below, which means no filing-verified financial STATEMENT is available · estimates 2026-08-04 · prices 2026-08-04, quote timestamp 1785873603 = 2026-08-04T20:00:03Z ($231.57, −0.66%; 50-DMA $224.58; 200-DMA $204.77; RSI 47.9; MACD +2.80) · knowledge-base claims 2026-08-04. Fiscal note: Welltower's fiscal year is the calendar year. All figures come from the Synthos vendor data file for WELL or from the SEC filings in the WELL archive; no figure comes from memory, recall or external retrieval.
- Filing archive contents and the extraction limitation that shapes this entire dive: 10-K filed 2026-02-12 (fiscal 2025); 10-Q filed 2026-04-29 (March 2026 quarter); 10-Q filed 2026-07-28 (June 2026 quarter); 8-K filed 2026-07-13; 8-K filed 2026-07-27; 8-K filed 2026-07-28 (second-quarter results). The WELL archive is flagged
tables: falsein the filings index — NO financial-statement tables were preserved in extraction. This is materially more damaging for a REIT than for an operating company, because the 10-Q's MD&A explicitly contains the reconciliations we most need and we can see their headings but not their contents: "The tables below reflect the reconciliation of FFO to NICS, the most directly comparable U.S. GAAP measure"; "the reconciliation of consolidated NOI to net income"; "the reconciliation of our consolidated NOI to same store NOI"; "the reconciliation of EBITDA to net income"; "the reconciliation of Adjusted EBITDA to net income"; and "the reconciliation of our leverage ratios to our balance sheets." Every one of those is the number a REIT is judged on, and none is available to us. All filing figures quoted in this dive therefore come from narrative prose — the dividend declaration, the acquisition programme, the impairment charge, the construction-conversion cost and the same-store property counts — and no balance sheet, income statement or FFO reconciliation as at 2026-06-30 was obtainable. - Where the filings contradicted or corrected the vendor (detailed in Section 7): the absence of any funds-from-operations figure identified as the central limitation, with the 10-Q confirmed to contain the reconciliation and the table confirmed lost in extraction;
priceToEarningsDilutedRatioTTM(122.5x),returnOnEquityTTM(3.15%),returnOnInvestedCapitalTTM(0.96%),dividendPayoutRatioTTM(152.4%) andinterestCoverageRatioTTM(0.92x) ALL REJECTED as depreciation artefacts — D&A was $2,139M against operating income of $355M in 2025, and adding it back gives interest coverage of roughly 3.8x rather than 0.92x — together with the vendor's B−/3 composite rating, which propagates the same artefact into a grade;propertyPlantEquipmentNetof $2,158M against $67,303M of total assets rejected as an unusable description of a property company, whilegoodwillandintangibleAssetsof ZERO are accepted and highlighted as a genuine quality signal;epsdilutedfound NULL in all fifteen rows (the fifth instance in this batch, alongside UNP, QCOM, DIS and GILD); theearn_calper-share series rejected as internally inconsistent ($1.13, $1.02, $0.61 reported against computed GAAP EPS of $0.136, $1.003, $0.328 — matching only one of three);est.epsAvgflagged as having an unverifiable basis and NOT used for fair value (fiscal-2025 $1.826 against computed GAAP EPS of $1.379 and operating cash flow per share of $4.24 — neither one nor the other);est.ebitdaAvg/ebitAvgrejected on a fixed-ratio fabrication signature (33.16% and 11.32% of revenue in all eight years against actual fiscal-2025 figures of 21.7% and 3.3%);freeCashFlowof $2,848M rejected as economically meaningless for a REIT, since acquisition capital flows through investing rather than capex; the acquisition programme of "more than $5 billion of seniors housing acquisitions in the second half of the year" added entirely from the 10-Q, along with the $0.85 quarterly dividend declaration, the 221st-consecutive-payment record, the $27,181,000 first-half impairment on 12 properties, and the $450,080-per-unit construction-conversion cost — none of which appears in any vendor field; andlastDividendof $2.96 identified as the TTM total against a filing-declared $0.85 quarterly rate, a $3.40 forward run-rate and a 1.47% forward yield — a 15% correction, the largest of its kind in this batch. Where vendor and filing AGREED — worth recording:netDebtof $16,347M is arithmetically correct because Welltower carries $0 of short-term investments, one of only three clean instances in this batch;seg_prodsums to within 1.9% andseg_geoto within 1.6% of reported revenue; and the quarterly revenue series matches the earnings calendar, including the June quarter's $3,544.6M against a $3,403.3M estimate. - Basis note: no earnings basis could be established for this name. GAAP diluted EPS is computable but is a depreciation artefact.
est.epsAvgmatches neither GAAP EPS nor a plausible FFO figure and its basis is unverified. Theearn_calactuals are internally inconsistent. Funds from operations, the correct measure, is unavailable. All valuation in this dive therefore runs on price-to-operating-cash-flow-per-share (~53x), price-to-sales (13.2x) and price-to-book (3.52x), each of which is a proxy, and the loss of precision is stated at every point of use. Operating cash flow is NOT funds from operations — it includes working-capital movements and excludes certain FFO adjustments — and readers should not treat the 53x figure as an FFO multiple. - Estimate coverage — the thinnest in this batch: 5 analysts on the per-share line for fiscal 2026, 2027 and 2028; only 3 on fiscal 2026 revenue and 6 on fiscal 2027; and ONE analyst on both the fiscal-2029 and fiscal-2030 per-share lines. The fiscal-2030 revenue estimate of $29.988B against fiscal-2029's $18.296B is a 63.9% single-year jump on three analysts. Fiscal 2029 and fiscal 2030 are excluded entirely, and the fiscal-2026 to fiscal-2028 revenue lines are used only for cross-checking, never as a primary anchor.
- Peer note: the vendor peer set mixes property types — American Tower, Digital Realty, Equinix and Prologis are towers, data centres and logistics, not healthcare comparables. The genuine peers are Ventas (the only one of comparable scale), National Health Investors, LTC Properties, Global Medical REIT and Universal Health Realty. No peer multiples are supplied in the file, so no peer-multiple comparison is drawn — a material loss on this name specifically, because relative funds-from-operations multiples are the standard method in this sector and we have neither the multiple nor a comparable.
- Fair-value caveat — the most important disclosure in this dive: the $185 / $232 / $280 anchors are built on price-to-operating-cash-flow-per-share and price-to-sales, because no funds-from-operations figure is available from the vendor payload or from the extracted filings. They are materially less precise than the anchors in the other eleven dives in this batch. The base is sensitivity-disclosed: 45x operating cash flow per share gives $197, fifteen percent BELOW spot; 60x gives $262, above the street's median. The whole answer lives in a 45-60x band on a PROXY measure, which is the widest honest uncertainty in this batch, and no greater precision is claimed. The bull case at $280 sits above the street's $275 high and is disclosed as such. The single most useful development available to this name is documentary rather than market-driven: a verifiable FFO-per-share figure would replace the widest fair-value uncertainty here with an ordinary one.
- Timing: second-quarter 2026 results were released 2026-07-27, eight days before this dive, beating on revenue by 4.2% ($3,544.6M against $3,403.3M) and landing essentially in line on a per-share figure whose basis we could not verify ($0.61 against $0.617). The board declared a $0.85 quarterly dividend on the same date, payable 2026-08-20 as the 221st consecutive quarterly payment. The next print is 2026-10-26, 83 days away. The larger catalyst is unscheduled: the more-than-$5-billion seniors-housing acquisition programme disclosed for the second half. 2026-08-04 was a firm broad market and WELL fell 0.66% — one of only two declines among the twelve names in this batch on the day.
- Accessibility note: no information in this dive is conveyed by colour. All emphasis is carried by bold text, table structure and explicit labelling.
- Not investment advice. Independent research, educational and informational only, never personalised. No recommendation to buy, sell or hold any security is made to any person.
- Version: 2026-08-04-full.